Skip to Content

Mercy Medical Center first in Stark County to use new stent to treat heart disease


Mercy Medical Center first in Stark County to use new stent to treat heart disease

Mercy Medical Center recently became the first hospital in Stark County to treat a patient with the newly approved SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent from Boston Scientific. Dilip Patel, M.D., an interventional cardiologist with Mercy Cardiovascular Institute (MCI), performed the procedure.

Stents are tiny mesh tubes doctors use to prop open clogged arteries, allowing blood to flow freely to the heart. The SYNERGY Stent, with its bioabsorbable polymer, offers simultaneous drug and polymer absorption. Designed for faster healing, the SYNERGY Stent provides medication that inhibits coronary blockages from recurring while eliminating permanent polymer exposure, which has been associated with complications such as vessel renarrowing and blood clots.

“Bringing the most advanced medical technologies to our community directly supports our mission to provide outstanding patient care,” said Ahmed Sabe, M.D., medical director, MCI. “Early adoption of the SYNERGY Stent, the first and only bioabsorbable polymer drug eluting stent in the U.S., reinforces our commitment to deliver advanced treatment to our patients.” 

“We are pleased to be working closely with Dr. Patel and Dr. Sabe at Mercy Medical Center to ensure patients can access this innovative technology,” said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. “In development for more than 10 years, the SYNERGY Stent reflects our commitment to bringing meaningful change to interventional cardiologists with the most complete portfolio of clinical solutions to best treat their patients.” said Ballinger. The SYNERGY Stent is being studied in more than 15,000 patients worldwide.

Mercy Medical Center is a ministry of the Sisters of Charity Health System.


Media Resources